Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663

Watchlist Manager
Bharat Immunologicals and Biologicals Corporation Ltd Logo
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Watchlist
Price: 23.32 INR -0.81%
Market Cap: 1B INR
Have any thoughts about
Bharat Immunologicals and Biologicals Corporation Ltd?
Write Note

Gross Margin
Bharat Immunologicals and Biologicals Corporation Ltd

-185.1%
Current
-21%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-185.1%
=
Gross Profit
-141.6m
/
Revenue
76.5m

Gross Margin Across Competitors

Country IN
Market Cap 1B INR
Gross Margin
-185%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 299.8B USD
Gross Margin
67%
Country US
Market Cap 159.1B USD
Gross Margin
60%
Country US
Market Cap 124.7B USD
Gross Margin
86%
Country US
Market Cap 114.8B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 137.3B AUD
Gross Margin
52%
Country US
Market Cap 86.2B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34B EUR
Gross Margin
89%

Profitability Report

View the profitability report to see the full profitability analysis for Bharat Immunologicals and Biologicals Corporation Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-185.1%
=
Gross Profit
-141.6m
/
Revenue
76.5m
What is the Gross Margin of Bharat Immunologicals and Biologicals Corporation Ltd?

Based on Bharat Immunologicals and Biologicals Corporation Ltd's most recent financial statements, the company has Gross Margin of -185.1%.